As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
Every year, more than 100 million people worldwide develop the sexually transmitted disease gonorrhoea, with health consequences such as infertility, transmission of the disease to newborn babies, and increased risk of HIV infections. There has been a 63 per cent rise in gonorrhoea in Australia over the past five years.
Gonorrhoea is caused by bacteria which can rapidly develop resistance to all known antibiotics – commonly called ‘superbugs’. Scientists at Monash University say they discovered how the gonorrhea superbug evades the immune system, opening up a way for therapies that prevent this process and allowing the body’s natural defenses to kill the bug. The team published its study (“Outer Membrane Vesicles from Neisseria gonorrhoeae Target PorB to Mitochondria and Induce Apoptosis”) in PLOS Pathogens.
The preclinical pharmacology department of Medicilon has been active in this field for many years, and has provided a variety of reliable animal models for different targets and pathways for the evaluation of inflammatory immune disease treatments to support successful clinical translation.
Thomas Naderer, Ph.D., and Pankaj Deo, Ph.D., and their team from the Monash Biomedicine Discovery Institute describe how Neisseria gonorrhoea creates vesicles that attack immune cells.
“Neisseria gonorrhorae causes the sexually transmitted disease gonorrhoea by evading innate immunity. Colonizing the mucosa of the reproductive tract depends on the bacterial outer membrane porin, PorB, which is essential for ion and nutrient uptake. PorB is also targeted to host mitochondria and regulates apoptosis pathways to promote infections. How PorB traffics from the outer membrane of N. gonorrhorae to mitochondria and whether it modulates innate immune cells, such as macrophages, remains unclear. Here, we show that N. gonorrhorae secretes PorB via outer membrane vesicles (OMVs). Purified OMVs contained primarily outer membrane proteins including oligomeric PorB,” write the investigators.
“The porin was targeted to mitochondria of macrophages after exposure to purified OMVs and wild type N. gonorrhorae. This was associated with loss of mitochondrial membrane potential, release of cytochrome c, activation of apoptotic caspases and cell death in a time-dependent manner. Consistent with this, OMV-induced macrophage death was prevented with the pan-caspase inhibitor, Q-VD-PH. This shows that N. gonorrhorae utilizes OMVs to target PorB to mitochondria and to induce apoptosis in macrophages, thus affecting innate immunity.”
Using super-resolution microscopy, the team found that these membrane vesicles interacted with macrophages, triggering these to die in an orchestrated suicide process. Dr. Naderer said that this new understanding of how the gonorrhea bacteria interact and cause the death of immune system cells “may lead to strategies to combat gonorrhea infection and its symptoms”.
The research may also provide information as to how other bacteria evade the immune system and be unaffected by antibiotics, he added.